Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06414122 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer Patients

Study acronym: MOMENT
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 10 months later Sep 2026 → Aug 2028
See other at-risk trials from University of Cologne

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Sep 2026 to Aug 2028
    • Start date: Jun 2025 to Aug 1, 2026
    v5
  2. Start date: Sep 2024 to Jun 2025v4
  3. Start date: Jul 2024 to Sep 2024v3
  4. Interventions: conventional exercise training (Other), mid-frequency whole-body electromyostimulation (Other), nutritional therapy (Other) to conventional exercise training (Other), mid-frequency whole-body electromyostimulation (WB-EMS) (Other), nutritional therapy (Other)
    • Secondary endpoints: details revised at 2 of 7 entries
    • Study description expanded, about 1 word
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to assess the efficacy of modulated mid-frequency whole-body electromyostimulation (WB-EMS) combined with nutritional therapy in patients with gastrointestinal cancer.
Trial Details
NCT Number NCT06414122
Lead Sponsor University of Cologne
Conditions
(from sponsor)		 Oesophageal Cancer, Gastric Cancer, Duodenal Cancer, Colorectal Cancer
Related terms Colorectal Neoplasms, Duodenal Neoplasms, Esophageal Neoplasms, Stomach Neoplasms
Enrollment 88 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov